truncation issues [General Sta­tis­tics]

posted by Loky do – Egypt, 2020-06-24 03:23 (299 d 07:47 ago) – Posting: # 21570
Views: 1,933

Hello Dears,

For certain products, ema product-specific bioequivalence guidance states that the main PK variables: AUC0-72,...etc (also stated in the study protocol), Is that mean any subject who miss 72 h will be excluded from AUC0-72 calculations? if yes, there will be around 25% of subjects missed this interval, is that will be acceptable?

Thanks in advance

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 17 (0 registered, 17 guests [including 3 identified bots]).
Forum time: Monday 11:11 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz